315 related articles for article (PubMed ID: 18456372)
1. Possible anticancer agents: QSAR analogs of glutamamide: synthesis and pharmacological activity of 1,5-N,N'-disubstituted-2-(substituted benzenesulphonyl) glutamamides.
Samanta S; Alam SM; Panda P; Jha T
Eur J Med Chem; 2009 Jan; 44(1):70-82. PubMed ID: 18456372
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, pharmacological activity and comparative QSAR modeling of 1,5-N,N'-substituted-2-(substituted naphthalenesulphonyl) glutamamides as possible anticancer agents.
Halder AK; Adhikary N; Maity MK; Jha T
Eur J Med Chem; 2010 May; 45(5):1760-71. PubMed ID: 20133022
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, antitumor evaluation, molecular modeling and quantitative structure-activity relationship (QSAR) of some novel arylazopyrazolodiazine and triazine analogs.
El-Shafei A; Fadda AA; Khalil AM; Ameen TA; Badria FA
Bioorg Med Chem; 2009 Jul; 17(14):5096-105. PubMed ID: 19527933
[TBL] [Abstract][Full Text] [Related]
4. 5-N-Substituted-2-(substituted benzenesulphonyl) glutamines as antitumor agents. Part II: synthesis, biological activity and QSAR study.
Samanta S; Srikanth K; Banerjee S; Debnath B; Gayen S; Jha T
Bioorg Med Chem; 2004 Mar; 12(6):1413-23. PubMed ID: 15018914
[TBL] [Abstract][Full Text] [Related]
5. Possible antineoplastic agents: Part XIII. Synthesis, biological evaluation and QSAR studies of some 1-(substituted benzenesulphonyl)-5-oxopyrrolidine-2-carboxylic acid derivatives.
Purkayastha SK; Jha T; Pal DK; De AU
Anticancer Drug Des; 1993 Apr; 8(2):95-100. PubMed ID: 8494605
[TBL] [Abstract][Full Text] [Related]
6. Syntheses, biological evaluation and QSAR study on antitumor activity of 1,5-N,N'-disubstituted-2-(substituted benzenesulphonyl) glutamamides.
Srikanth K; Debnath B; Jha T
Bioorg Med Chem; 2002 Jun; 10(6):1841-54. PubMed ID: 11937342
[TBL] [Abstract][Full Text] [Related]
7. The influence of three newly synthesized pyrimidine-containing compounds on micronucleus induction and tumor growth.
Nersesyan A; Muradyan R; Arsenyan F
J BUON; 2007; 12(4):521-7. PubMed ID: 18067211
[TBL] [Abstract][Full Text] [Related]
8. Design and QSAR study of analogs of alpha-tocopherol with enhanced antiproliferative activity against human breast adenocarcinoma cells.
Nikolic KM
J Mol Graph Model; 2008 Jan; 26(5):868-73. PubMed ID: 17616411
[TBL] [Abstract][Full Text] [Related]
9. A TOPological Sub-structural Molecular Design (TOPS-MODE)-QSAR approach for modeling the antiproliferative activity against murine leukemia tumor cell line (L1210).
Molina-Ruiz R; Saíz-Urra L; Rodríguez-Borges JE; Pérez-Castillo Y; González MP; García-Mera X; Cordeiro MN
Bioorg Med Chem; 2009 Jan; 17(2):537-47. PubMed ID: 19114309
[TBL] [Abstract][Full Text] [Related]
10. Design and QSAR study of analogs of gamma-tocotrienol with enhanced antiproliferative activity against human breast cancer cells.
Nikolic K; Agababa D
J Mol Graph Model; 2009 Apr; 27(7):777-83. PubMed ID: 19117779
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of 1-(2,6-dichlorophenyl)-3-methylene-1,3-dihydro-indol-2-one derivatives and in vitro anticancer evaluation against SW620 colon cancer cell line.
Virsodia V; Manvar A; Upadhyay K; Loriya R; Karia D; Jaggi M; Singh A; Mukherjee R; Shaikh MS; Coutinho EC; Shah A
Eur J Med Chem; 2009 Mar; 44(3):1355-62. PubMed ID: 18316139
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological validation of novel pyrazole derivatives with anticancer activity guided by 3D-QSAR analysis.
Vujasinović I; Paravić-Radičević A; Mlinarić-Majerski K; Brajša K; Bertoša B
Bioorg Med Chem; 2012 Mar; 20(6):2101-10. PubMed ID: 22341245
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Hep2 and HeLa cell proliferation in vitro and EAC tumor growth in vivo by Lapemis curtus (Shaw 1802) venom.
Karthikeyan R; Karthigayan S; Sri Balasubashini M; Somasundaram ST; Balasubramanian T
Toxicon; 2008 Jan; 51(1):157-61. PubMed ID: 17936322
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and evaluation of novel 6-chloro-/fluorochromone derivatives as potential topoisomerase inhibitor anticancer agents.
Ishar MP; Singh G; Singh S; Sreenivasan KK; Singh G
Bioorg Med Chem Lett; 2006 Mar; 16(5):1366-70. PubMed ID: 16332438
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro antitumor activity of new substituted thiopyrimidine acyclic nucleosides and their thioglycoside analogs.
El-Sayed WA; Rashad AE; Awad SM; Ali MM
Nucleosides Nucleotides Nucleic Acids; 2009 Apr; 28(4):261-74. PubMed ID: 20183580
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of anticancer activity of Cleome gynandra on Ehrlich's Ascites Carcinoma treated mice.
Bala A; Kar B; Haldar PK; Mazumder UK; Bera S
J Ethnopharmacol; 2010 May; 129(1):131-4. PubMed ID: 20307641
[TBL] [Abstract][Full Text] [Related]
17. Quantitative structure activity relationship (QSAR) studies of some substituted benzenesulphonyl glutamines as tumour suppressors.
Srikanth K; Kumar CA; Goswami D; De AU; Jha T
Indian J Biochem Biophys; 2001; 38(1-2):120-3. PubMed ID: 11563323
[TBL] [Abstract][Full Text] [Related]
18. N,N'-disubstituted L-isoglutamines as novel cancer chemotherapeutic agents.
Khalid M; Burzynski SR
Drugs Exp Clin Res; 1987; 13 Suppl 1():57-60. PubMed ID: 3569017
[TBL] [Abstract][Full Text] [Related]
19. QSAR analysis of antitumor active amides and quinolones from thiophene series.
Bertosa B; Aleksić M; Karminiski-Zamola G; Tomić S
Int J Pharm; 2010 Jul; 394(1-2):106-14. PubMed ID: 20472047
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antitumor screening of new 1,7-diphenyl-3-(1,3-disubstituted-1H-pyrazole-4-carbonyl)-[1,2,4]triazolo[4,3-a]pyrimidin-5(1H)-ones.
Shawali AS; Sherif SM; Darwish MA; El-merzabani MM
Arch Pharm Res; 2010 Jan; 33(1):55-60. PubMed ID: 20191343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
